Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202807
Company: CATALENT
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
NAPROXEN SODIUM NAPROXEN SODIUM EQ 200MG BASE CAPSULE;ORAL Over-the-counter None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/04/2019 ORIG-1 Approval

Label is not available on this site.

NAPROXEN SODIUM

The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.

CAPSULE;ORAL; EQ 200MG BASE
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD Application No. Company
NAPROXEN SODIUM NAPROXEN SODIUM EQ 200MG BASE CAPSULE;ORAL Over-the-counter Yes 021920 BIONPHARMA INC
NAPROXEN SODIUM NAPROXEN SODIUM EQ 200MG BASE CAPSULE;ORAL Over-the-counter No 202807 CATALENT
NAPROXEN SODIUM NAPROXEN SODIUM EQ 200MG BASE CAPSULE;ORAL Over-the-counter No 208363 PURACAP PHARM LLC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English